Quality of CKD Care: Don’t Take the Neighborhood Out of It Yet
Jessica L. Harding, Laura C. Plantinga
Kidney Medicine · 2021
doi:10.1016/j.xkme.2021.06.003 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Chronic kidney disease (CKD) is a major public health problem, with an estimated U.S. adult prevalence of 15%.1 Moreover, 9 in 10 adults do not know they have CKD,1 and quality of care remains suboptimal: for example, from 2013 to 2016, only 43% of U.S. adults with known CKD and diabetes received recommended medical treatment with angiotensin-converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs).2 The burden of CKD, including suboptimal CKD care, is not equally distributed among populations, with evidence of substantial inequalities across individual socioeconomic status (SES) for a variety of CKD outcomes, including incidence,3 disease progression,4 CKD awareness,5 nephrology care,6 and kidney transplant access.
Abstract licence: CC BY-NC-ND
References17
17 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.